How SARS-CoV-2 defeats the innate immune response
The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell’s innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses. A Kobe University discovery may point the way to the development of more effective drugs against this and possibly similar…
Read More
